Cargando…

Effects of Angiotensin-II Receptor Blocker on Inhibition of Thrombogenicity in a Canine Atrial Fibrillation Model

BACKGROUND AND OBJECTIVES: Angiotensin-II receptor blockers (ARBs) are known to reduce the development of atrial fibrillation (AF) through reverse-remodeling. However, the effect of ARBs on thrombogenicity in AF remains unknown. MATERIALS AND METHODS: Twelve dogs were assigned to control (n=4), ARB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Jong-Il, Jung, Jae Seung, Kim, Min Kyung, Sim, Jaemin, Kim, Jin Seok, Lim, Hong Euy, Park, Sang Weon, Kim, Young-Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891598/ https://www.ncbi.nlm.nih.gov/pubmed/27275170 http://dx.doi.org/10.4070/kcj.2016.46.3.335

Ejemplares similares

Antiplatelet Therapy Combinations and Thrombogenicity in Patients with Non-Valvular Atrial Fibrillation
por: Park, Yongwhi, et al.
Publicado: (2017)

Extracellular Vesicles and Thrombogenicity in Atrial Fibrillation
por: Berezin, Alexander E., et al.
Publicado: (2022)

Effect of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Patients Following Ablation of Atrial Fibrillation
por: Park, Jeong-Hwan, et al.
Publicado: (2009)

Long-term clinical outcomes of catheter ablation in patients with atrial fibrillation predisposing to tachycardia-bradycardia syndrome: a long pause predicts implantation of a permanent pacemaker
por: Kim, Dong-Hyeok, et al.
Publicado: (2018)

Characteristics and Outcomes of Atrial Tachycardia Originating from the Sinus Venosus during Catheter Ablation of Atrial Fibrillation
por: Park, Yae Min, et al.
Publicado: (2013)

Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation
por: Naccarelli, Gerald V, et al.
Publicado: (2009)

Imaging and biophysical modelling of thrombogenic mechanisms in atrial fibrillation and stroke
por: Qureshi, Ahmed, et al.
Publicado: (2023)

Atrial Substrate Underlies the Recurrence after Catheter Ablation in Patients with Atrial Fibrillation
por: Baek, Yong-Soo, et al.
Publicado: (2020)

Coexisting Sustained Tachyarrthymia in Patients With Atrial Fibrillation Undergoing Catheter Ablation
por: Jang, Jin-Kun, et al.
Publicado: (2010)

The Effects of Single Nucleotide Polymorphisms in Korean Patients with Early-onset Atrial Fibrillation after Catheter Ablation
por: Park, Yae Min, et al.
Publicado: (2020)

Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis
por: Ma, Haotian, et al.
Publicado: (2021)

The extent of complex fractionated atrial electrograms in the left atrium reflects age‐related electrical remodeling in patients with persistent atrial fibrillation
por: Park, Yae Min, et al.
Publicado: (2019)

Clinical Significance of Adenosine-Induced Atrial Fibrillation after Complete Pulmonary Vein Isolation
por: Choi, Yun Young, et al.
Publicado: (2022)

Identification of Markers Associated With Development of Stroke in “Clinically Low‐Risk” Atrial Fibrillation Patients
por: Shin, Seung Yong, et al.
Publicado: (2019)

Preventive Effects of the Angiotensin-II Receptor Blocker on Atrial Remodeling in an Ischemic Heart Failure Model of Rats
por: Yoon, Namsik, et al.
Publicado: (2013)

2018 Korean Guideline of Atrial Fibrillation Management
por: Joung, Boyoung, et al.
Publicado: (2018)

Atrial fibrillation is associated with increased risk of lethal ventricular arrhythmias
por: Kim, Yun Gi, et al.
Publicado: (2021)

Oral Anticoagulants for Atrial Fibrillation Patients with Active Cancer
por: Kim, Do Young, et al.
Publicado: (2018)

Prevalence, predictors and management of left atrial appendage thrombogenic milieu in atrial fibrillation with low thromboembolic risk
por: Qiao, Yu, et al.
Publicado: (2023)

Mechanistic modelling of Virchows triad to assess thrombogenicity and stroke risk in atrial fibrillation patients
por: Qureshi, A, et al.
Publicado: (2022)

Impact of age on thromboembolic events in patients with non‐valvular atrial fibrillation
por: Kim, Yun Gi, et al.
Publicado: (2019)

Therapeutic implications of galectin-3 in patients with atrial fibrillation
por: Lee, Kwang-No, et al.
Publicado: (2022)

Impact of pulmonary artery pressure on recurrence after catheter ablation in patients with atrial fibrillation
por: Choi, Yun Young, et al.
Publicado: (2023)

Left Atrial Dysfunction, Fibrosis and the Risk of Thromboembolism in Patients With Paroxysmal and Persistent Atrial Fibrillation
por: Kim, Hee-Dong, et al.
Publicado: (2022)

Angiotensin-Receptor Blocker, Angiotensin-Converting Enzyme Inhibitor, and Risks of Atrial Fibrillation: A Nationwide Cohort Study
por: Hsieh, Yu-Cheng, et al.
Publicado: (2016)

Role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cryoballoon ablation outcomes for paroxysmal atrial fibrillation
por: Al-Seykal, Ibragim, et al.
Publicado: (2022)

Association of Depression With Atrial Fibrillation in South Korean Adults
por: Kim, Yun Gi, et al.
Publicado: (2022)

Angiotensin Receptor Blocker for Stroke Prevention in Atrial Fibrillation: beyond Blood Pressure Lowering?
por: Choi, Eue-Keun
Publicado: (2016)

Inadvertently Developed Ventricular Fibrillation during Electrophysiologic Study and Catheter Ablation: Incidence, Cause, and Prognosis
por: Park, Yae Min, et al.
Publicado: (2013)

Congenital Left Atrial Bands with Atrial Fibrillation
por: Jang, Won Young, et al.
Publicado: (2017)

Gender-related Difference in Clinical Outcome of the Patient with Atrial Fibrillation after Radiofrequency Catheter Ablation
por: Roh, Seung-Young, et al.
Publicado: (2018)

Genome-wide association study-based prediction of atrial fibrillation using artificial intelligence
por: Kwon, Oh-Seok, et al.
Publicado: (2022)

The impact of body weight and diabetes on new-onset atrial fibrillation: a nationwide population based study
por: Kim, Yun Gi, et al.
Publicado: (2019)

Risk Factors for Ischemic Stroke in Atrial Fibrillation Patients Undergoing Radiofrequency Catheter Ablation
por: Kim, Yun Gi, et al.
Publicado: (2019)

Premature ventricular contraction is associated with increased risk of atrial fibrillation: a nationwide population-based study
por: Kim, Yun Gi, et al.
Publicado: (2021)

Angiotensin II receptor blockers and cardiovascular protection: Focus on left ventricular hypertrophy regression and atrial fibrillation prevention
por: Cuspidi, Cesare, et al.
Publicado: (2008)

Assessment of the Left Ventricular Diastolic Function and Its Association with the Left Atrial Pressure in Patients with Atrial Fibrillation
por: Kim, Mi-Na, et al.
Publicado: (2020)

Clinical and Echocardiographic Risk Factors Predict Late Recurrence after Radiofrequency Catheter Ablation of Atrial Fibrillation
por: Kim, Yun Gi, et al.
Publicado: (2019)

Simvastatin Attenuates the Oxidative Stress, Endothelial Thrombogenicity and the Inducibility of Atrial Fibrillation in a Rat Model of Ischemic Heart Failure
por: Cho, Kyoung-Im, et al.
Publicado: (2014)

Beneficial effects of an angiotensin-II receptor blocker on structural atrial reverse-remodeling in a rat model of ischemic heart failure
por: YOON, NAMSIK, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_tlvtevtpeh24jbi53e4l7ccjcg